US Drug Recall Register
Class III · Low risk Terminated Initiated Oct 13, 2022 (4 years ago)

Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Stability Specifications

What was recalled

Fyarro (sirolimus protein-bound particles for injectable suspension (albumin-bound), 100 mg per vial, NDC 80803-153-50, manufactured for Aadi Bioscience, Inc, CA.

Recalling firm
Aadi Bioscience
NDC code
80803-153-50
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0059-2023

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Albumin recalls

See all